Category:
Active Pharmaceutical Ingredients
CAS NO:
1448232-80-1
Standard:
In-house Standards,
Oncology Lung Cancer
Naquotinib is an investigational small-molecule inhibitor targeting the JAK/STAT pathway, primarily developed for oncology applications. The core synthetic process involves multi-step organic coupling reactions to achieve high purity standards. Molecular Formula: C24H26N8O3; CAS No.: 2157947-45-0.
Strictly for laboratory use only; not approved for clinical therapy. Store under inert atmosphere at -20°C to prevent degradation. Personnel must utilize appropriate PPE including nitrile gloves and safety goggles during handling due to potential toxicity.